$SVFC - Receives US Patent for its Stem Cell Extraction

New Post Public Reply Private Reply Replies (0) Message Board
2TellDeTroot

$SVFC - Receives US Patent for its Stem Cell Extraction Technology

NEW YORK, June 13, 2013 /PRNewswire via COMTEX/ -- IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented method for deriving blood vessel originated vascular cells from adipose (fat) tissue by use of ultrasonic cavitation has been made official. This technology involves an innovative mechanical method for the separation of stromal vascular fraction cells from adipose (fat) tissue, without the use of enzymes. Vascular cells derived by IntelliCell's proprietary method are potentially useful in bringing the promise of regenerative medicine to many therapeutic and aesthetic procedures. Investors can access the published patent at the US Patent website by entering the patent # 8,440,440. Link to patent website: http://patft.uspto.gov/netahtml/PTO/srchnum.htm
IntelliCell's Chairman and CEO, Dr. Steven Victor, stated "Our Company is very pleased to announce today that with the publishing of our patent, our technology is now protected and we expect our international patent publication in a short time."

About IntelliCell BioSciences, Inc.

IntelliCell BioSciences is a Regenerative Medicine company developing novel technologies that address the regenerative, curative and preventative conditions of disease states with high unmet clinical needs. The Company has several patent-pending applications including the patent that was recently published, an industry unique method of obtaining autologous stromal vascular fraction cells (SVF) cells from the vasculature surrounding adipose tissue containing adult stem cells and a robust population of regenerative healing cells. The Company is also pioneering the development of autologous and allogeneic cells from living and non-living tissue donors for research purposes. IntelliCell is planning a series of in-human clinical studies with top tier universities for the treatment of osteoarthritis, multiple sclerosis, lower limb ischemic wounds, and gum regeneration in the oral cavity as well as medical aesthetics. The Company has developed a first in class cGTP cellular processing facility in New York City, purpose built and designed to be fully integrated into an ambulatory surgery center.

Forward-Looking Statements

Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "will reach," "will change," "will soon," "should," "could," "would," "may," "can" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contacts:Anna Rhodes, IntelliCell BioSciences, Inc. Phone: (646) 576-8710 Email: arhodes@intellicellbiosciences.com

Melissa Diaz, South Street Media, Inc. Phone: (917) 937-8968 Email: info@southstreetmedia.com

SOURCE IntelliCell BioSciences, Inc.

http://rt.prnewswire.com/rt.gif?NewsItemId=NE...d=20130613

www.prnewswire.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 7

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading
World Fire Congress 2026 Champions Global Fire Safety

Updated Category News Views 8

Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 5

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 1

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 7

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 7

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading

Top 5 Most Recently Viewed Articles

ImmunityBio Faces Lawsuit; Investors Have Lead Role

Updated Category News Views 12

ImmunityBio's Legal Turbulence: What's at Stake? ImmunityBio, Inc. (NASDAQ: IBRX) shares are riding a wave of rough waters. If you're clutching at those shares, you've got a chance, but the clock's ticking quicker than a hot summer's day. You've got until May 26, 2026, to throw your hat in the ring and take charge of this securities fraud class action lawsuit. Don’t...

Continue Reading
Brompton Split Corp. Class A Share ETF Announces New Changes

Updated Category News Views 212

Brompton Split Corp. Class A Share ETF Announces Increased Distributions In a recent announcement, Brompton Funds has revealed an exciting development for investors in the Brompton Split Corp. Class A Share ETF (TSX: CLSA). Due to impressive growth in net asset value (NAV), the ETF will see its monthly distribution rise to $0.13 per unit starting from October through...

Continue Reading
Willow Lane Acquisition Corp. Successfully Completes IPO

Updated Category News Views 116

Willow Lane Acquisition Corp. Successfully Completes IPO Willow Lane Acquisition Corp. has successfully finalized its initial public offering, raising a total of $126.5 million through the sale of 12,650,000 units. This impressive amount includes 1,650,000 units optioned by the underwriters, indicating strong market interest in the offering. Overview of the IPO The...

Continue Reading
Intelecy Welcomes Anna Olsson as New COO to Drive Global Growth

Updated Category News Views 100

Intelecy Promotes Anna Olsson to Chief Operating Officer Intelecy, a key player in Norway's industrial AI landscape, is excited to announce that Anna Olsson is stepping up from her role as Chief Commercial Officer (CCO) to become the new Chief Operating Officer (COO). This move aligns with the company's ambitious plans for global expansion and reflects the significant...

Continue Reading
Brock Group Welcomes Shenna Bradshaw as General Counsel

Updated Category News Views 432

Brock Group Welcomes Shenna Bradshaw as General Counsel The Brock Group proudly announces the appointment of Shenna Bradshaw as General Counsel, a pivotal role where she will concentrate on corporate governance, compliance, litigation, and risk management. Frank Bardonaro, Jr., CEO of the Brock Group, shared his enthusiasm, stating that Shenna's leadership skills and...

Continue Reading